HN1998000102A - SOLTRILIZED COMPOSITIONS OF SERTRALINA - Google Patents

SOLTRILIZED COMPOSITIONS OF SERTRALINA

Info

Publication number
HN1998000102A
HN1998000102A HN1998000102A HN1998000102A HN1998000102A HN 1998000102 A HN1998000102 A HN 1998000102A HN 1998000102 A HN1998000102 A HN 1998000102A HN 1998000102 A HN1998000102 A HN 1998000102A HN 1998000102 A HN1998000102 A HN 1998000102A
Authority
HN
Honduras
Prior art keywords
soltrilized
sertralina
compositions
present
invention refers
Prior art date
Application number
HN1998000102A
Other languages
Spanish (es)
Inventor
Pfizer Products Inc
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN1998000102(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN1998000102A publication Critical patent/HN1998000102A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPOSICIONES SOLUBILIZADAS DE SERTRALINA.THE PRESENT INVENTION REFERS TO SOLTRILIZED COMPOSITIONS OF SERTRALINA.

HN1998000102A 1997-07-01 1998-07-01 SOLTRILIZED COMPOSITIONS OF SERTRALINA HN1998000102A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
HN1998000102A true HN1998000102A (en) 1999-01-08

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1998000102A HN1998000102A (en) 1997-07-01 1998-07-01 SOLTRILIZED COMPOSITIONS OF SERTRALINA

Country Status (34)

Country Link
EP (1) EP0999829A1 (en)
JP (1) JP2000514100A (en)
KR (1) KR100366373B1 (en)
CN (1) CN1261794A (en)
AP (1) AP1192A (en)
AR (3) AR015917A1 (en)
AU (1) AU742535B2 (en)
BG (1) BG103918A (en)
BR (1) BR9810739A (en)
CA (1) CA2290974C (en)
CO (1) CO4940495A1 (en)
DZ (1) DZ2548A1 (en)
EA (1) EA002481B1 (en)
HN (1) HN1998000102A (en)
HR (1) HRP980377A2 (en)
HU (1) HUP0002236A3 (en)
ID (1) ID23429A (en)
IL (1) IL133076A (en)
IS (1) IS5260A (en)
MA (1) MA24587A1 (en)
NO (1) NO996520L (en)
OA (1) OA11243A (en)
PA (1) PA8454301A1 (en)
PE (1) PE97199A1 (en)
PL (1) PL337804A1 (en)
SK (1) SK181099A3 (en)
TN (1) TNSN98124A1 (en)
TR (1) TR199903297T2 (en)
TW (1) TW550087B (en)
UA (1) UA67741C2 (en)
UY (1) UY25071A1 (en)
WO (1) WO1999001120A1 (en)
YU (1) YU68299A (en)
ZA (1) ZA985708B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200200357A (en) 1999-12-23 2003-10-15 Pfizer Products Inc. Pharmaceutical compositions providing increased concentrations of the drug substance
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
BR0113626A (en) 2000-08-30 2003-06-17 Pfizer Prod Inc Sustained-Release Formulations for Growth Hormone Secretors
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
JP2010520897A (en) * 2007-03-12 2010-06-17 ディーエスエム アイピー アセッツ ビー．ブイ． Cosmetic composition
TW201129557A (en) * 2009-12-29 2011-09-01 Kowa Co Pharmaceutical composition for oral administration
EP2520299A1 (en) * 2009-12-29 2012-11-07 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
CN109908354A (en) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 Sertraline hydrochloride takes orally concentrate and its preparation process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
DK0415612T3 (en) * 1989-08-30 1993-12-13 Pfizer Use of sertraline for the treatment of addictions to chemical substances
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
IS5260A (en) 1999-11-19
SK181099A3 (en) 2000-07-11
KR20010013365A (en) 2001-02-26
IL133076A (en) 2003-12-10
BG103918A (en) 2000-07-31
CN1261794A (en) 2000-08-02
PA8454301A1 (en) 2000-09-29
TNSN98124A1 (en) 2005-03-15
KR100366373B1 (en) 2003-01-14
AU7544898A (en) 1999-01-25
YU68299A (en) 2002-06-19
HUP0002236A2 (en) 2003-08-28
HUP0002236A3 (en) 2003-12-29
CA2290974C (en) 2004-04-27
UA67741C2 (en) 2004-07-15
NO996520L (en) 2000-02-29
PL337804A1 (en) 2000-09-11
HRP980377A2 (en) 1999-04-30
JP2000514100A (en) 2000-10-24
WO1999001120A1 (en) 1999-01-14
AP9801280A0 (en) 1998-06-30
EA199900962A1 (en) 2000-08-28
EA002481B1 (en) 2002-06-27
BR9810739A (en) 2000-09-12
AU742535B2 (en) 2002-01-03
AR040279A2 (en) 2005-03-23
IL133076A0 (en) 2001-03-19
ZA985708B (en) 2000-01-10
ID23429A (en) 2000-04-20
TW550087B (en) 2003-09-01
OA11243A (en) 2003-07-24
AR015917A1 (en) 2001-05-30
CO4940495A1 (en) 2000-07-24
AP1192A (en) 2003-07-23
PE97199A1 (en) 1999-10-05
MA24587A1 (en) 1998-12-31
TR199903297T2 (en) 2000-07-21
UY25071A1 (en) 2000-12-29
AR040280A2 (en) 2005-03-23
CA2290974A1 (en) 1999-01-14
DZ2548A1 (en) 2003-02-08
EP0999829A1 (en) 2000-05-17
NO996520D0 (en) 1999-12-28

Similar Documents

Publication Publication Date Title
HN1999000089A (en) ZIPRASIDONE FORMULATIONS
HN1998000086A (en) DERIVATIVES OF 9 - DESOFO - 9 AZA - 9A - HOMOERITROMICINA A - C - 4 SUBSTITUTED.
HN1998000036A (en) PIRAZINE COMPOUND
HN1998000011A (en) ARILSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES
HN1999000155A (en) 4-CARBOXYAMINO-2-METHYL-1,2,3,4-TETRAHYDROKINOLINS
HN1997000090A (en) PIRIDILPIRROL COMPOUNDS
HN1997000166A (en) 1-PESTICIDED ARILPIRAZOLES
HN1999000066A (en) PHARMACEUTICAL FORMULATIONS
HN1997000023A (en) LACTAMA DERIVATIVES
HN1998000132A (en) THERAPEUTIC COMBINATIONS
HN1998000057A (en) NICOTINAMIDE DERIVATIVES
HN1997000126A (en) INDAZOL DERIVATIVES
HN1998000030A (en) 2-AMINO-6- (4FENOXI-2-SUBSTITUTED) -PIRIDINES SUBSTITUTED
HN1998000124A (en) COMBINATION THERAPY
HN1998003689A (en) AZETIDINS
HN1998000106A (en) PARENTERAL COMPOSITIONS OF ALATROFLAXACINO
HN1998000158A (en) ISOQUINOLINS
HN1998000028A (en) OTROPISOMEROS DE 3 HETEROARIL - 4 (3H) - QUINAZOLINONAS.
HN1998000045A (en) PHARMACEUTICAL COMPOSITIONS
HN1998000199A (en) THERAPEUTIC AGENTS
HN1998000193A (en) TRIAZINE COMPOUNDS
HN1998000102A (en) SOLTRILIZED COMPOSITIONS OF SERTRALINA
HN1998000165A (en) DOPHYTILINE POLYMORPHES
HN1999000202A (en) HYGROMYCIN DERIVATIVES
HN1997000119A (en) REPELLENT FORMULATIONS